Isfort RJ, Kerckaert GA, LeBoeuf RA. 1996. Comparison of the standard and reduced pH Syrian Hamster Embryo (SHE) cell in vitro transformation assays in predicting the carcinogenic potential of chemicals. Mutat Res 1:11–63.
Kuiper HA, Kleter GA, Noteborn HP, Kok EJ. 2001. Assessment of the food safety issues related to genetically modified foods. Plant J 27:503–528.
Morita T, Nagaki T, Fukuda I, Okumura K. 1992. Clastogenicity of low pH to various cultured mammalian cells. Mutat Res 268:297–305.
OFAS (Office of Food Additive Safety). 2001. Toxicological Principles for the Safety Assessment of Direct Food Additives and Color Additives Used in Food. Redbook II–Draft. Washington, DC: OFAS, Food and Drug Administration.
OFAS. 2003. Redbook 2000 Toxicological Principles for the Safety of Food Ingredients. Online. CSFAN, Food and Drug Administration. Available at http://www.cfsan.fda.gov/~redbook/red-toca.html. Accessed June 19, 2003.
Pennie WD, Kimber I. 2002. Toxicogenomics: Transcript profiling and potential application to chemical allergy. Toxicol In Vitro 16:319–326.
Pennie WD, Tugwood JD, Oliver GJ, Kimber I. 2000. The principles and practice of toxicogenomics: Applications and opportunities. Toxicol Sci 54:277–283.
Preston RJ, Hoffmann GR. 2001. Genetic toxicology. In: Klaassen CD, ed. Casarett and Doull’s Toxicology: The Basic Science of Poisons. New York: McGraw-Hill. Pp. 321–350.
Robinson C. 2001. Genetic Modification Technology and Food: Consumer Health and Safety. ILSI Europe Concise Monograph Series. Washington, DC: ILSI Press.
Roche O, Trube G, Zuegge J, Pflimlin P, Alanine A, Schneider G. 2002. A virtual screening method for prediction of the hERG potassium channel liability of compound libraries. Chembiochem 3:455–459.
Rojas E, Lopez MC, Valverde M. 1999. Single cell gel electrophoresis assay: Methodology and applications. J Chromatogr B 722:225–254.
Sathyamoorthy N, Wang TT, Phang JM. 1994. Stimulation of pS2 expression by diet-derived compounds. Cancer Res 54:957–961.
Sinha AK, Linscombe VA, Gollapudi BB, McClintock ML, Flake RE, Bodner KM. 1984. The incidence of spontaneous cytogenetic aberrations in lymphocytes cultured from normal humans for 48 and 72 H. Can J Genet Cytol 26:528–531.
Stearns DM, Wise JP, Patierno SR, Wetterhahn KE. 1995. Chromium (III) picolinate produces chromosome damage in Chinese hamster ovary cells. FASEB J 9:1643–1648.
Stearns DM, Silveira SM, Wolf KK, Luke AM. 2002. Chromium (III) tris (picolinate) is mutagenic at the hypoxanthine (guanine) phosphoribosyltransferase locus in Chinese hamster ovary cells. Mut Res 513:135–142.
Tennant RW, Margolin BH, Shelby MD, Zeiger E, Haseman JK, Spalding J, Caspary W, Resnick M, Stasiewicz S, Anderson B, Minor R. 1987. Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science 236:933–941.
Tice RR, Strauss GHS. 1995. The single cell gel electrophoresis/comet assay: A potential tool for detecting radiation-induced DNA damage in humans. Stem Cells 13:207S–214S.
Ulrich R, Friend SH. 2002. Toxicogenomics and drug discovery: Will new technologies help us produce better drugs? Nat Rev Drug Discov 1:84–88.
Waring JF, Halbert DN. 2002. The promise of toxicogenomics. Curr Opin Mol Ther 4:229–235.
Yang CS, Landau JM, Huang MT, Newmark HL. 2001. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 21:381–406.
Zeiger E. 1998. Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: Premises, promises, and performance. Regul Toxicol Pharmacol 28:85–95.